December 19, 2024 FDA 0 Comments Evolution of orphan drug – Healthcare Economist A study by Fermaglich and Miller (2023) evaluated trends in orphan drug designations and approvals after the Orphan Drug ... Read More
June 5, 2024 Comparative Effectiveness 0 Comments Challenges in Conducting Economic Evaluations for Orphan Drugs in Rare Diseases – Healthcare Economist Why is it so hard to estimate the value of orphan drugs indicated for the treatment of rare diseases? ... Read More